Education
About Us
Working with TipRanks
Follow Us
Genscript Biotech (HK:1548)
:1548
1548 Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
1548 Stock 12 Month Forecast
Average Price Target
HK$21.87
▲(78.38% Upside)
| Highest Price TargetHK$21.90 | Average Price TargetHK$21.87 | Lowest Price TargetHK$21.90 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Morgan Stanley
Reiterated
03/14/25
Jefferies
HK$23
Buy
87.60%
Upside
Reiterated
06/02/24
Buy Rating on Genscript Biotech Amidst Market Volatility and Geopolitical Tensions: An Undervalued Opportunity
J.P. Morgan
HK$27→HK$16
Buy
30.51%
Upside
Reiterated
05/17/24
Genscript Biotech Corp (1548:HK) PT Lowered to HK$16 at JPMorganJPMorgan analyst Yang Huang lowered the price target on Genscript Biotech Corp (1548:HK) to HK$16.00 (from HK$27.00) while maintaining a Overweight rating.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Morgan Stanley
Reiterated
03/14/25
Jefferies
HK$23
Buy
87.60%
Upside
Reiterated
06/02/24
Buy Rating on Genscript Biotech Amidst Market Volatility and Geopolitical Tensions: An Undervalued Opportunity
J.P. Morgan
HK$27→HK$16
Buy
30.51%
Upside
Reiterated
05/17/24
Genscript Biotech Corp (1548:HK) PT Lowered to HK$16 at JPMorganJPMorgan analyst Yang Huang lowered the price target on Genscript Biotech Corp (1548:HK) to HK$16.00 (from HK$27.00) while maintaining a Overweight rating.
1548 Analyst Recommendation Trends
Rating
Jan 22
Sep 23
Mar 24
May 24
Mar 25
Strong Buy
0
1
2
3
3
Buy
0
0
0
0
0
Hold
1
1
1
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
2
3
3
3
Each month's total comprises the sum of three months' worth of ratings.
1548 Financial Forecast
1548 Stock Forecast FAQ
What is HK:1548’s average 12-month price target, according to analysts?
Based on analyst ratings, Genscript Biotech’s 12-month average price target is HK$21.87.
What is HK:1548’s upside potential, based on the analysts’ average price target?
Genscript Biotech has 78.38% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Genscript Biotech a Buy, Sell or Hold?
Genscript Biotech has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Genscript Biotech’s share price target?
The average share price target for Genscript Biotech is HK$21.87. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$21.90 ,and the lowest forecast is HK$21.90. The average share price target represents 78.38% Increase from the current price of HK$12.26.
The highest analyst share price target is HK$21.90 ,and the lowest forecast is HK$21.90. The average share price target represents 78.38% Increase from the current price of HK$12.26.
What do analysts say about Genscript Biotech?
Genscript Biotech’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of Genscript Biotech?
To buy shares of HK:1548, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.